Medial tarsal arteries

From WikiMD's WELLNESSPEDIA

(Redirected from Arteria tarsea medialis)

Gray553.png

== Medial Tarsal Arteries ==

The medial tarsal arteries are small arteries that branch from the dorsalis pedis artery and supply blood to the medial aspect of the foot. These arteries play a crucial role in the vascularization of the tarsal bones and the surrounding soft tissues.

Anatomy[edit]

The medial tarsal arteries typically arise from the dorsalis pedis artery, which is a continuation of the anterior tibial artery. They are usually two or three in number and course medially over the tarsal bones.

Function[edit]

The primary function of the medial tarsal arteries is to supply oxygenated blood to the medial part of the foot, including the tarsal bones, the talus, and the surrounding soft tissues. This blood supply is essential for the proper functioning and health of these structures.

Clinical Significance[edit]

The medial tarsal arteries can be involved in various medical conditions, such as peripheral artery disease and diabetes mellitus, which can lead to compromised blood flow and subsequent complications in the foot. Proper assessment of these arteries is important in the diagnosis and management of foot-related vascular conditions.

Related Structures[edit]

See Also[edit]

References[edit]


External Links[edit]

This article is a stub related to anatomy. You can help WikiMD by expanding it!

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.